TUDCA-PBA Composition for Neural Cell Protection Against Oxidative Stress
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for neurodegenerative diseases such as Alzheimer's disease are inadequate, as they either temporarily alleviate symptoms or have significant side effects without addressing the underlying pathology, and there is a need for therapies that can reduce oxidative stress and mitochondrial dysfunction.
Innovation Solution
A combination of tauroursodeoxycholic acid (TUDCA) and phenylbutyric acid (PBA) is administered to reduce reactive oxygen metabolite-mediated oxidative damage, regulate redox homeostasis, and mitigate mitochondrial dysfunction, thereby improving cell viability and treating neurodegenerative diseases.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If current Alzheimer's disease treatments (NMDA receptor blockers or acetyl cholinesterase inhibitors) are used to increase neural excitement, then cognitive symptoms are temporarily alleviated, but side effects increase and disease pathology is not addressed
Solution Approach 1:
The patent converts the harmful oxidative stress and mitochondrial dysfunction that drive Alzheimer's pathology into therapeutic targets. By using TUDCA and PBA to reduce reactive oxygen metabolites and regulate redox homeostasis, the treatment transforms the disease mechanism from a harmful force into a treatable pathway, addressing the root cause rather than just symptoms
Solution Approach 2:
The patent introduces TUDCA and PBA as intermediary substances that mediate between the oxidative stress/dysfunction and cellular damage. These compounds act as protective intermediaries that reduce reactive oxygen metabolite-mediated damage and regulate redox balance, preventing direct harm to neurons while treating the underlying pathology
2Reliability
If current Alzheimer's disease treatments are used to increase neural excitement, then cognitive symptoms are temporarily alleviated, but the underlying pathology (oxidative stress and mitochondrial dysfunction) is not addressed
Solution Approach 1:
The patent converts the harmful oxidative stress and mitochondrial dysfunction that drive Alzheimer's pathology into therapeutic targets. By using TUDCA and PBA to reduce reactive oxygen metabolites and regulate redox homeostasis, the treatment transforms the disease mechanism from a harmful force into a treatable pathway, addressing the root cause rather than just symptoms
Solution Approach 2:
The patent enables cells to self-protect and self-regulate by enhancing their endogenous antioxidant defenses and mitochondrial function. TUDCA and PBA work by regulating redox homeostasis and reducing mitochondrial dysfunction, allowing cells to maintain their own viability and resist oxidative damage without continuous external intervention
3Reliability
If TUDCA and PBA are used in combination to reduce oxidative damage and regulate redox homeostasis, then cell viability is significantly improved, but treatment complexity increases
Solution Approach 1:
The patent merges two distinct therapeutic mechanisms into a single combination treatment. TUDCA (a bile acid) and PBA (a phenylbutyric acid) are combined to simultaneously reduce reactive oxygen metabolite-mediated oxidative damage and regulate redox homeostasis, creating a synergistic effect that addresses multiple aspects of Alzheimer's pathology through one integrated therapy
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The combination of TUDCA and PBA synergistically enhances cell protection against oxidative stress, reducing cell death and improving neuronal viability, providing a potential therapeutic benefit for neurodegenerative diseases by slowing disease progression and alleviating symptoms.
Implementation Method 1
reduce reactive oxygen metabolite-mediated oxidative damage in a cell
Implementation Method 2
regulating redox homeostasis in a cell
Data Source
AI summary
This invention relates to methods and compositions for use improving cell viability, particularly neural cell viability, and more particularly to methods and compositions for use improving cell viability by reducing reactive oxygen metabolite-mediated oxidative damage in a cell, regulating redox homeostasis in a cell, or reducing mitochondrial dysfunction in a cell. The invention further relates to the administration of the bile acid tauroursodeoxycholic acid (TUDCA) in combination with phenylbutyric Acid (PBA) to improve cell viability, and treat at least one symptom associated with, prevent the time of onset of, or slow the development of a disease related to oxidative stress.